Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden

Jiangwei Sun and colleagues investigate the long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa in a Swedish cohort.

Related Keywords

China , Sweden , Montreal , Quebec , Canada , United States , Stockholm , North Carolina , Texas , Swedish , Chinese , Karolinska Institutet , Bristol Myer Squibb , Vifor Pharma , Falk Pharma , Sanjay Basu , Tillotts Pharma , Swedish National Board Of Health , International Classification Of Diseases , Swedish Longitudinal Integrated Database For Health Insurance , Novartis , National Patient Register , Pfizer , Swedish Ethical Review Authority , Beker Foundation , Chinese Scholarship Council , Blackwell , International Classification Of Disease , Prometheus Laboratories Inc , Harvard Medical School , Swedish Research Council , Falk Foundation , American College Of Gastroenterology Senior Research Award , Creative Commons Attribution License , Statistics Sweden , Swedish National Board , Swedish Ethical Review , Index Pharma , Thermo Fisher Scientific , American College , Gastroenterology Senior Research Award , Epidemiology Strengthened , Pathology Reports , International Classification , Systematized Nomenclature , Swedish Total Population Register , Swedish Multi Generation Register , Total Population Register , Swedish Longitudinal Integrated Database , Health Insurance , Labour Market Studies , Prescribed Drug Register , College Station , Observational Studies , Regional Ethics Review Board , Therapeutic Chemical , Inflammatory Bowel Disease , Biopsy , Epidemiology , Endoscopy , Medical Risk Factors , Cancer Risk Factors , Ulcerative Colitis ,